Skip to main content

Why Is Artivion (AORT) Stock Rocketing Higher Today

AORT Cover Image

What Happened?

Shares of medical device company Artivion (NYSE: AORT) jumped 20.3% in the morning session after it reported strong second-quarter 2025 earnings that surpassed analyst expectations and raised its full-year guidance. The company's revenue for the quarter grew 15.3% year-over-year to $113 million, beating Wall Street's estimates. Its non-GAAP profit of $0.24 per share was also 92% above consensus forecasts, showcasing significant bottom-line strength. Buoyed by the strong performance, Artivion lifted its full-year revenue guidance to a midpoint of $439 million. The results also revealed a marked improvement in cash generation, as its free cash flow margin expanded to 10.4%, up from 3.7% in the same quarter last year. This comprehensive beat and positive outlook fueled investor optimism, leading to the stock's jump.

Is now the time to buy Artivion? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Artivion’s shares are not very volatile and have only had 5 moves greater than 5% over the last year. Moves this big are rare for Artivion and indicate this news significantly impacted the market’s perception of the business.

The previous big move we wrote about was 2 days ago when the stock gained 3% on the news that investment firm Stifel raised its price target on the stock to $36 from $30, while maintaining a Buy rating. The adjustment followed Stifel's conversations with six physicians who utilized Artivion's aortic arch dissection repair stent (AMDS) after its FDA approval. The doctors reportedly offered positive commentary about the device, noting it simplified a complex procedure and enhanced results over existing treatments. This feedback reinforced Stifel's optimistic view on the technology's launch and its potential within what the firm estimated was a $150 million US market.

Artivion is up 37.7% since the beginning of the year, and at $38.66 per share, has set a new 52-week high. Investors who bought $1,000 worth of Artivion’s shares 5 years ago would now be looking at an investment worth $1,807.

Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.